Charcot-Marie-Tooth Disease |
AR-CMT2; Charcot-Marie-Tooth disease, type 1; Charcot-Marie-Tooth disease, type 2; Charcot-Marie-Tooth disease, type 4; Charcot-Marie-Tooth Disorder; congenital hypomyelination; Dejerine-Sottas syndrome; DSN; DSS; hereditary motor and sensory neuropathy; HMSN; Peroneal Muscular Atrophy; PMA; Roussy-Levy Syndrome |
Clinical Trial: The Role of MMPs in Orthodontic Tooth Movement
This study is currently recruiting patients.
Verified by National Taiwan University Hospital December 2003
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| Orthodontic | Procedure: Orthodontic treatment | Phase I |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Single Blind, Active Control, Factorial Assignment, Efficacy Study
Official Title: The Role of Matrix Metalloproteinases in Orthodontic Treatment
Expected Total Enrollment: 12
Study start: January 2004; Expected completion: December 2005
Long treatment time is a major factor causing high fee for orthodontic treatment. Patients would have dental caries or periodontitis resulted from improper oral hygiene care during this long treatment period. Therefore, how to speed up the tooth movement which determines the duration of orthodontic treatment, can help more people to obtain good occlusion and esthetics. Orthodontic force on tooth induces bone resorption on the compression side and bone deposition on the tension side, thus bone remodels and then tooth moves. Therefore, bone resorption is the rate-limiting step of a lengthy orthodontic treatment.
Bone resorption is a complex process. The mineral component is dissolved by acid from osteoclasts. On the other hand, the organic components are digested with proteolytic enzymes secreted from osteoblasts and osteoclasts. We focus on our study on specific proteases which can digest extracellar matrix, called matrix-metalloproteinases (MMPs). Osteoblast-derived MMPs play an important role during initiation of bone resorption. However, the mechanism of its regulation is not clear. The past studies applied stretching or tension on single layer of cultured cells to characterize cellular response to the mechanical stimulation. Now we simulate part of the bone resorption process by cultivating osteocyte-like cells in three-dimension collagen gel under periodical compression.
In preliminary study, we focus on transcriptional changes of MMPs upon compression in an osteosarcoma cell lines MG-63. Initial data form microarray indicated specific increase of two MMPs expression after one day of compression. This increased expression was specific because the levels of house-keeping genes (ex. Beta-actin or GAPDH) and bone-specific markers were unaltered. Therefore, we proposed that increased MMPs expression of osteoblasts under compression is the first step for bone remodeling switching from synthesis to degradation of osteoid. In order to test this hypothesis, the following specific aims will be achieved:
- To test whether these two MMPs can be up-regulated during orthodontic treatment. Alveolar bone samples will be collected from partially impacted third molars after orthodontic uprighting for different period of time in volunteers. In situ hybridization and immunohistochemistry analysis for MMPs will reveal their roles in this physiological process.
- To optimize the regulation by changing magnitude and frequency of pressure, and characterize the time table for these changes..
Eligibility
Accepts Healthy Volunteers
Inclusion Criteria:
- two mandibular third molars containing at least one mesially anugular impaction with crown exposed to oral cavity
Exclusion Criteria:
- pregnancy
Location and Contact Information
Taiwan
Department of Dentistry, National Taiwan University Hospital, Taipei, Taiwan; Recruiting
Chung-Chen Yao, DDS, PhD, Principal Investigator
Chung-Chen Yao, DDS, PhD, Principal Investigator, National Taiwan University Hospital
More Information
Last Updated: September 9, 2005
Record first received: September 9, 2005
ClinicalTrials.gov Identifier: NCT00154518
Health Authority: Taiwan: Department of Health
ClinicalTrials.gov processed this record on 2005-09-13

Not Signed In -


